Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACAD | BMY | AMGN | GILD | REGN |
| Company | Acadia Pharmaceutica | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 16.98 | 48.21 | 264.63 | 66.25 | 913.97 |
| High | 17.30 | 48.57 | 265.72 | 66.72 | 920.73 |
| Low | 16.88 | 48.12 | 260.68 | 66.16 | 896.11 |
| Last | 17.03 | 48.46 | 264.85 | 66.37 | 894.09 |
| Change | -0.04 | +0.16 | +2.10 | +0.21 | +0.10 |
| % Change | -0.23% | +0.33% | +0.80% | +0.32% | +0.01% |
| Volume | 191,471 | 1,808,843 | 537,941 | 1,861,227 | 134,687 |
| 20-Day Average Volume | 1,292,310 | 10,856,944 | 2,099,300 | 5,995,130 | 418,108 |
| Previous Close | 17.07 | 48.30 | 262.75 | 66.16 | 893.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 17.73 | 50.83 | 272.37 | 69.89 | 935.22 |
| 20-Day Raw Stochastic | 21.18% | 12.17% | 15.35% | 8.00% | 8.15% |
| 20-Day Relative Strength | 30.84% | 38.40% | 39.46% | 30.08% | 35.06% |
| Weighted Alpha | -42.84 | -29.86 | +5.48 | -24.67 | +12.56 |
| Today's Opinion | 100% Sell | 72% Sell | 56% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 100% Sell | 72% Sell | 56% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 72% Sell | 24% Sell | 8% Sell | 72% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.64% since 04/12/24 | +0.35% since 04/12/24 | -0.87% since 04/12/24 | -2.25% since 04/12/24 | -0.79% since 04/12/24 |
| Low | 16.60 on 04/16/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 17.35 on 04/18/24 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 921.12 on 04/15/24 |
| 1-Month | |||||
| %Chg | -8.93% since 03/19/24 | -6.47% since 03/19/24 | -2.49% since 03/19/24 | -9.36% since 03/19/24 | -6.86% since 03/19/24 |
| Low | 16.60 on 04/16/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 19.00 on 03/21/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 979.26 on 03/21/24 |
| 3-Month | |||||
| %Chg | -37.60% since 01/19/24 | -3.31% since 01/19/24 | -13.92% since 01/19/24 | -23.77% since 01/19/24 | -3.84% since 01/19/24 |
| Low | 16.60 on 04/16/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 29.29 on 01/24/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -25.73% since 10/19/23 | -14.22% since 10/19/23 | -5.57% since 10/19/23 | -15.17% since 10/19/23 | +10.99% since 10/19/23 |
| Low | 16.60 on 04/16/24 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 769.19 on 10/27/23 |
| High | 32.59 on 12/22/23 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,812,658 | 97,892,464 | 140,812,720 | 82,374,304 | 98,126,128 |
| Shares Outstanding, K | 164,772 | 2,026,759 | 535,919 | 1,245,077 | 109,762 |
| Annual Sales | 726,440,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -61,290,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 231,040,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | 45,800,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 0.37 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.28 on 02/27/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/13/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.38 | 14.16 | 9.96 | 23.98 |